Skip to content

CDW clinical study

CDW clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080223789
Enrollment
20
Registered
2018-01-26
Start date
2018-01-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

investigational material(s) Generic name etc : CDW(food) INN of investigational material : N/A Therapeutic category code : --- Other Dosage and Administration for Investigational material : once/day,2

Sponsors

Rohto pharmaceutical CO.,LTD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Targets those who meet the following items. (1) Age: 20 to 60 years old (2) Person who uses PC, smartphone on a daily basis (3) A person who can take the test product in compliance with the specified periodic measurement schedule (4) A person who understands the purpose of the research and has signed a "consent form" with his / her own free will

Exclusion criteria

Exclusion criteria: (1) Person who is treated by ophthalmology and dermatology (except medical treatment of contact lens) (2) Those who are pregnant or nursing (3) Those who are taking medicines that are considered to affect research (4) Allergists

Design outcomes

Primary

MeasureTime frame
other Evaluation of eye appearance other Skin measurement result other Subjective symptoms of eyes and skin

Secondary

MeasureTime frame
other Easy to take the tablet

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026